Progression of Renal Dysfunction in Cardiac Transplantation After the Introduction of Everolimus in the Immunosuppressive Regime
Authors:
- Jose A. Moro LópezJLJose A. Moro López
- Luis AlmenarLALuis Almenar
- Luis Martínez-DolzLMLuis Martínez-Dolz
- Ignacio Sánchez-LázaroISIgnacio Sánchez-Lázaro
- Jaime AgüeroJAJaime Agüero
- Francisco BuendíaFBFrancisco Buendía
- Víctor OrtizVOVíctor Ortiz
- Antonio SalvadorASAntonio Salvador
- 27 February 2009
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (4) , 538-541
Abstract
The aim of this study was to analyze, in heart transplant patients, if renal function improvement after cyclosporine replacement by everolimus persists at the middle term and its predictors. We studied prospectively 56 patients in whom conversion was consecutively made. Forty-five patients completed the follow-up period. Significant improvement was observed at 6 and 12 months in plasma creatinine levels (1.92±0.7 vs. 1.67±0.6 and 1.69±0.6 mg/dL; P=0.047) and glomerular filtration rate (43.9±17 vs. 52.5±23 and 51.3±22.3 mL/min; P=0.004). Glomerular filtration rate increased in 32 patients (71%). Baseline characteristics comparison showed a lower percentage of patients with smoking history and new onset diabetes in responders group, but only previous smoking was shown as independent factor (Exp B: 0.083; 95% confidence interval: 0.010–0.793; P=0.024). No differences regarding age, gender, body mass index, disease leading to transplantation, time between transplantation and replacement, cardiovascular risk factors, lipid levels, and hematologic parameters were found.Keywords
This publication has 25 references indexed in Scilit:
- No Association Between Single Nucleotide Polymorphisms and the Development of Nephrotoxicity After Orthotopic Heart TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report—2007The Journal of Heart and Lung Transplantation, 2007
- Calcineurin Inhibitor–Free Immunosuppression Using Everolimus (Certican) in Maintenance Heart Transplant Recipients: 6 Months’ Follow-upThe Journal of Heart and Lung Transplantation, 2007
- Predictors of Decline in Renal Function After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Sirolimus in Cardiac Transplantation: Use as a Primary Immunosuppressant in Calcineurin Inhibitor–induced NephrotoxicityThe Journal of Heart and Lung Transplantation, 2005
- Improvement of Renal Dysfunction by Conversion From Calcineurin Inhibitors to Sirolimus After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- Drug Therapy in the Heart Transplant RecipientCirculation, 2004
- Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairmentThe Journal of Heart and Lung Transplantation, 2002
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984